103 related articles for article (PubMed ID: 11837381)
1. Bioequivalence study of a valsartan tablet and a capsule formulation after single dosing in healthy volunteers using a replicated crossover design.
Séchaud R; Graf P; Bigler H; Gruendl E; Letzkus M; Merz M
Int J Clin Pharmacol Ther; 2002 Jan; 40(1):35-40. PubMed ID: 11837381
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: a single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers.
Iqbal M; Khuroo A; Batolar LS; Tandon M; Monif T; Sharma PL
Clin Ther; 2010 Mar; 32(3):588-96. PubMed ID: 20399995
[TBL] [Abstract][Full Text] [Related]
3. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions.
Spínola AC; Almeida S; Filipe A; Neves R; Trabelsi F; Farré A
Clin Ther; 2009 Sep; 31(9):1992-2001. PubMed ID: 19843489
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic properties and bioequivalence of 2 formulations of valsartan 160-mg tablets: A randomized, single-dose, 2-period crossover study in healthy Korean male volunteers.
Kim JE; Ki MH; Yoon IS; Cho HJ; Kim RS; Tae Kim G; Kim DD
Clin Ther; 2014 Feb; 36(2):273-9. PubMed ID: 24529292
[TBL] [Abstract][Full Text] [Related]
5. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic comparison of 2 fixed-dose combination tablets of amlodipine and valsartan in healthy male Korean volunteers: a randomized, open-label, 2-period, single-dose, crossover study.
Kim Y; Son M; Lee D; Roh H; Son H; Chae D; Bahng MY; Park K
Clin Ther; 2013 Jul; 35(7):934-40. PubMed ID: 23870605
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and bioequivalence study of two brands of valsartan tablets in healthy male volunteers.
Zakeri-Milani P; Valizadeh H; Islambulchilar Z; Nemati M
Arzneimittelforschung; 2010; 60(2):76-80. PubMed ID: 20329655
[TBL] [Abstract][Full Text] [Related]
8. A Pharmacokinetic Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Volunteers.
Pan L; Belloni P; Ding HT; Wang J; Rubino CM; Putnam WS
Adv Ther; 2017 Sep; 34(9):2071-2082. PubMed ID: 28808905
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and bioequivalence study of valacyclovir hydrochloride capsules after single dose administration in healthy Chinese male volunteers.
Lin H; Tian Y; Tian JX; Zhang ZJ; Mao GG
Arzneimittelforschung; 2010; 60(3):162-7. PubMed ID: 20422949
[TBL] [Abstract][Full Text] [Related]
10. Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man.
Flesch G; Müller P; Lloyd P
Eur J Clin Pharmacol; 1997; 52(2):115-20. PubMed ID: 9174680
[TBL] [Abstract][Full Text] [Related]
11. Bioequivalence of single and multiple doses of venlafaxine extended-release tablets and capsules in the fasted and fed states: four open-label, randomized crossover trials in healthy volunteers.
Wright CW; Aikman MS; Werts E; Seabolt J; Haeusler JM
Clin Ther; 2009 Nov; 31(11):2722-34. PubMed ID: 20110014
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic interactions of valsartan and hydrochlorothiazide: an open-label, randomized, 4-period crossover study in healthy Egyptian male volunteers.
Hedaya MA; Helmy SA
Clin Ther; 2013 Jun; 35(6):846-61. PubMed ID: 23795576
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the pharmacokinetic and pharmacodynamic drug interactions between cilnidipine and valsartan, in healthy volunteers.
Lee J; Lee H; Jang K; Lim KS; Shin D; Yu KS
Drug Des Devel Ther; 2014; 8():1781-8. PubMed ID: 25336921
[TBL] [Abstract][Full Text] [Related]
14. Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
He YL; Ligueros-Saylan M; Sunkara G; Sabo R; Zhao C; Wang Y; Campestrini J; Pommier F; Dole K; Marion A; Dole WP; Howard D
J Clin Pharmacol; 2008 Jan; 48(1):85-95. PubMed ID: 17986525
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a pharmacokinetic interaction between valsartan and simvastatin in healthy subjects.
Sunkara G; Reynolds CV; Pommier F; Humbert H; Yeh C; Prasad P
Curr Med Res Opin; 2007 Mar; 23(3):631-40. PubMed ID: 17355744
[TBL] [Abstract][Full Text] [Related]
16. An interaction study with cimetidine and the new angiotensin II antagonist valsartan.
Schmidt EK; Antonin KH; Flesch G; Racine-Poon A
Eur J Clin Pharmacol; 1998 Feb; 53(6):451-8. PubMed ID: 9551704
[TBL] [Abstract][Full Text] [Related]
17. A new esomeprazole packet (sachet) formulation for suspension: in vitro characteristics and comparative pharmacokinetics versus intact capsules/tablets in healthy volunteers.
Bladh N; Blychert E; Johansson K; Backlund A; Lundin C; Niazi M; Pettersson G; Fjellman M
Clin Ther; 2007 Apr; 29(4):640-9. PubMed ID: 17617287
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
19. Bioequivalence of zonisamide orally dispersible tablet and immediate-release capsule formulations: results from two open-label, randomized-sequence, single-dose, two-period, two-treatment crossover studies in healthy male volunteers.
Maanen Rv; Bentley D
Clin Ther; 2009 Jun; 31(6):1244-55. PubMed ID: 19695391
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and bioequivalence of two formulations of rebamipide 100-mg tablets: a randomized, single-dose, two-period, two-sequence crossover study in healthy Korean male volunteers.
Cho HY; Yoon H; Park GK; Lee YB
Clin Ther; 2009 Nov; 31(11):2712-21. PubMed ID: 20110013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
